Cytyc Expands Women’s Health Niche With Novacept Menorrhagia Treatment

Cytyc will double its sales force targeting ob/gyn physicians to 200 reps following its acquisition of Novacept, in an effort to make NovaSure the top-selling menorrhagia treatment system

More from Archive

More from Medtech Insight